Table 13.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1993 to 2002

Recipients with Heart-Lung Transplants

		Year of Transplant
		1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Transplants		60	71	69	39	62	47	51	48	27	32
Tx With Follow-up Immunosuppression Info		44	45	53	22	34	27	27	29	21	20
Corticosteroids	Category Usage	97.7%	100.0%	100.0%	100.0%	100.0%	96.3%	100.0%	100.0%	95.2%	100.0%
	Steroids	97.7%	100.0%	100.0%	100.0%	100.0%	96.3%	100.0%	100.0%	95.2%	100.0%
Cyclosporine	Category Usage	86.4%	93.3%	58.5%	86.4%	55.9%	66.7%	55.6%	58.6%	47.6%	55.0%
	Cyclosporin	86.4%	86.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	2.3%	6.7%	34.0%	36.4%	5.9%	0.0%	0.0%	6.9%	0.0%	0.0%
	Neoral	0.0%	2.2%	35.8%	50.0%	50.0%	66.7%	55.6%	44.8%	42.9%	50.0%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	6.9%	4.8%	5.0%
Tacrolimus	Category Usage	13.6%	6.7%	30.2%	13.6%	47.1%	37.0%	51.9%	58.6%	76.2%	65.0%
	FK506	13.6%	6.7%	30.2%	13.6%	47.1%	37.0%	51.9%	58.6%	76.2%	65.0%
Antimetabolites	Category Usage	93.2%	95.6%	88.7%	81.8%	88.2%	92.6%	92.6%	93.1%	95.2%	95.0%
	Azathioprine	93.2%	93.3%	73.6%	68.2%	64.7%	44.4%	48.1%	44.8%	47.6%	55.0%
	Mycophenolate mofetil	0.0%	2.2%	22.6%	13.6%	32.4%	51.9%	48.1%	62.1%	61.9%	55.0%
Other	Category Usage	0.0%	0.0%	0.0%	0.0%	0.0%	7.4%	3.7%	10.3%	0.0%	5.0%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	7.4%	3.7%	10.3%	0.0%	5.0%

Source: OPTN/SRTR Data as of May 3, 2004.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.